HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Common variants in HNF-1 alpha and risk of type 2 diabetes.

AbstractAIMS/HYPOTHESIS:
Mutations in the hepatocyte nuclear factor 1-alpha gene (HNF-1alpha, now known as the transcription factor 1 gene [TCF1]) cause the most common monogenic form of diabetes, MODY3, but it is not known if common variants in HNF-1a are associated with decreased transcriptional activity or phenotypes related to type 2 diabetes, or whether they predict future type 2 diabetes.
SUBJECTS AND METHODS:
We studied the effect of four common polymorphisms (rs1920792, I27L, A98V and S487N) in and upstream of the HNF-1alpha gene on transcriptional activity in vitro, and their possible association with type 2 diabetes and insulin secretion in vivo.
RESULTS:
Certain combinations of the I27L and A98V polymorphisms in the HNF-1alpha gene showed decreased transcriptional activity on the target promoters glucose transporter 2 (now known as solute carrier family 2 [facilitated glucose transporter], member 2) and albumin in both HeLa and INS-1 cells. In vivo, these polymorphisms were associated with a modest but significant impairment in insulin secretion in response to oral glucose. Insulin secretion deteriorated over time in individuals carrying the V allele of the A98V polymorphism (n = 2,293; p = 0.003). In a new case-control (n = 1,511 and n = 2,225 respectively) data set, the I27L polymorphism was associated with increased risk of type 2 diabetes, odds ratio (OR) = 1.5 (p = 0.002; multiple logistic regression), particularly in elderly (age > 60 years) and overweight (BMI > 25 kg/m(2)) patients (OR = 2.3, p = 0.002).
CONCLUSIONS/INTERPRETATION:
This study provides in vitro and in vivo evidence that common variants in the MODY3 gene, HNF-1alpha, influence transcriptional activity and insulin secretion in vivo. These variants are associated with a modestly increased risk of late-onset type 2 diabetes in subsets of elderly overweight individuals.
AuthorsJ Holmkvist, C Cervin, V Lyssenko, W Winckler, D Anevski, C Cilio, P Almgren, G Berglund, P Nilsson, T Tuomi, C M Lindgren, D Altshuler, L Groop
JournalDiabetologia (Diabetologia) Vol. 49 Issue 12 Pg. 2882-91 (Dec 2006) ISSN: 0012-186X [Print] Germany
PMID17033837 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Blood Glucose
  • Hepatocyte Nuclear Factor 1-alpha
  • Insulin
  • Arginine
  • Glucose
Topics
  • Adult
  • Amino Acid Substitution
  • Arginine (pharmacology)
  • Blood Glucose (metabolism)
  • Body Weight
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 (epidemiology, genetics)
  • Female
  • Genetic Variation
  • Glucose (pharmacology)
  • Hepatocyte Nuclear Factor 1-alpha (genetics)
  • Humans
  • Insulin (metabolism)
  • Insulin Secretion
  • Male
  • Middle Aged
  • Mutagenesis, Site-Directed
  • Overweight
  • Plasmids
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: